Skip Navigation Links

Bookmark and Share
Medigen’s MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

on 10/26/2021
TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World H...

Full "IntellAsia: Resources" article

Disclaimer | Terms Of Use And Privacy Statement

© Metals News. All rights reserved.